We recently compiled a list of the 20 High Growth Mega Cap Stocks You Can Buy And Hold For Next 5 Years. In this article, we ...

AstraZeneca AZN stock has risen 8.6% in the past month, mainly due to mixed fourth-quarter results and a positive update from management regarding ongoing investigations at its China subsidiary ...

A fresh earnings release was the news development powering AstraZeneca's (NASDAQ: AZN) share price higher on Thursday. Investors were clearly impressed by the pharmaceutical company's numbers ...

Investors with a lot of money to spend have taken a bullish stance on AstraZeneca (NASDAQ:AZN). And retail traders should know. We noticed this today when the positions showed up on publicly ...

For example, let’s take a look at AstraZeneca (NASDAQ:AZN,LSE:AZN). In early 2023, the pharmaceutical company licensed CMG901, a Phase 1 clinical-stage antibody drug conjugate for treating ...

The company's dominance in CF in the past decade -- which led to excellent financial results and stock-market performances -- proves as much: AstraZeneca's financial results were strong for most ...

Looking at the universe of stocks we cover at Dividend Channel, on 2/21/25, Vestis Corp (Symbol: VSTS), ONE Gas, Inc. (Symbol: OGS), and AstraZeneca plc (Symbol: AZN) will all trade ex-dividend ...

SAN FRANCISCO, Feb. 20, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced the sale of its China subsidiary to AstraZeneca for approximately $160 million. “Today ...

Astrazeneca (AZN) closed the latest trading ... Meanwhile, the Dow experienced a drop of 0.31%, and the technology-dominated Nasdaq saw a decrease of 0.51%. The pharmaceutical's stock has climbed ...

(RTTNews) - AstraZeneca (AZN.L ... the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew Mariathasan in New York, with ...

AstraZeneca AZN will report its fourth-quarter and full-year 2024 earnings on Feb. 6, before market open. The Zacks Consensus Estimate for sales and earnings is pegged at $14.28 billion and $1.06 ...

Inc. (NASDAQ: FGEN) today announced the sale of its China subsidiary to AstraZeneca for approximately $160 million. “Today, we announced the sale of FibroGen China to AstraZeneca, our long-time ...